2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
申请人:American Cyanamid Company
公开号:EP1051407A1
公开(公告)日:2000-11-15
US6071903A
申请人:——
公开号:US6071903A
公开(公告)日:2000-06-06
US6544984B1
申请人:——
公开号:US6544984B1
公开(公告)日:2003-04-08
[EN] 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS<br/>[FR] ACIDES 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAPEZINE-3-HYDROXAMIQUES UTILISES EN TANT QU'INHIBITEURS DE METALLOPROTEASES MATRICIELLES
申请人:AMERICAN CYANAMID COMPANY
公开号:WO1999037625A1
公开(公告)日:1999-07-29
(EN) Compounds are provided having formula (I), wherein R, R1, R2, R3 and R4 are defined in the specification, which have matrix metalloproteinase inhibiting activity.(FR) L'invention se rapporte à des composés représentés par la formule (I) dans laquelle R, R1, R2, R3 et R4 sont définis dans la description. Ces composés présentent une activité inhibitrice vis à vis des métalloprotéases matricielles.
[EN] 2,3,4,5-TETRAHYDRO-1H-[1,4]BENZODIAZEPINE-3-HYDROXAMIC ACID AS MATRIX METALLOPROTEINASE INHIBITORS<br/>[FR] ACIDES 2,3,4,5-TETRAHYDRO-1H-[1,4]BENZODIAZEPINE-3-HYDROXAMIQUES UTILISES COMME INHIBITEURS DES METALLOPROTEINASES MATRICIELLES
申请人:AMERICAN CYANAMID CO
公开号:WO2000044730A1
公开(公告)日:2000-08-03
Compounds having formula (1) are useful in treating disease conditions mediated by matrix metalloproteinases and TACE, such as tumor growth, osteoarthritis, rheumatoid arthritis and degenerative cartilage loss.